Balyasny Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-297,182	Closed	-$39.1M	–	2052
2020 Q4	$39.1M	Buy	+297,182	New	+$39.1M	0.22%	96
2018 Q4	–	Sell	-32,095	Closed	-$320K	–	1687
2018 Q3	$320K	Sell	32,095 -48,505	-60%	-$484K	﹤0.01%	1267
2018 Q2	$1.64M	Buy	+80,600	New	+$1.64M	0.01%	828